Table 1 Baseline information of the 126 patients
Characteristics | Number | Percentage (%) |
|---|---|---|
Gender | ||
Male | 112 | 88.9 |
Female | 14 | 11.1 |
Median age (range) | 63 (47–80) | |
Karnofsky performance status | ||
70 | 2 | 1.6 |
80 | 50 | 39.7 |
90 | 74 | 58.7 |
Pathology | ||
Squamous | 125 | 99.2 |
Adenocarcinoma | 1 | 0.8 |
Initial T categorya | ||
T1 | 10 | 7.9 |
T2 | 19 | 15.1 |
T3 | 88 | 69.9 |
T4 | 9 | 7.1 |
Initial N categorya | ||
N0 | 37 | 29.4 |
N1 | 62 | 49.2 |
N2 | 18 | 14.3 |
N3 | 9 | 7.1 |
Initial overall stagea | ||
I | 6 | 4.7 |
II | 39 | 31.0 |
III | 63 | 50.0 |
IVA | 18 | 14.3 |
Initial treatment | ||
Surgery + adjuvant CRT | 67 | 53.2 |
Radical CRT | 40 | 31.7 |
Surgery + adjuvant RT | 9 | 7.1 |
Surgery + adjuvant Chemotherapy | 5 | 4.0 |
Surgery alone | 5 | 4.0 |
The boundary of recurrent lymph node | ||
Clear | 95 | 75.4 |
Non-clear | 31 | 24.6 |
Number of recurrent lymph node | ||
Single | 48 | 38.1 |
Multiple | 78 | 61.9 |
Lesion of recurrent lymph node | ||
Cervical only | 37 | 29.4 |
Supraclavicular only | 64 | 50.8 |
Mediastinum only | 23 | 18.3 |
Two or more lesions | 2 | 1.5 |
Recurrent lymph node-related symptoms | ||
Pain | 79 | 62.7 |
Number | 7 | 5.6 |
Local disease | ||
Under control | 87 | 69.0 |
Progression | 39 | 31.0 |